Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults

Alvaro Cobo-Calvo; María Sepúlveda; Hyacintha d'Indy; Thais Armangué; Anne Ruiz; Elisabeth Maillart; Caroline Papeix; Bertrand Audoin; Helene Zephir; Damien Biotti; Jonathan Ciron; Francoise Durand-Dubief; Nicolas Collongues; Xavier Ayrignac; Pierre Labauge; Eric Thouvenot; Alexis Montcuquet; Romain Deschamps; Nuria Solà-Valls; Sara Llufriu; Yolanda Blanco; Jerome de Seze; Sandra Vukusic; Albert Saiz; Romain Marignier; OFSEP Group; REEM Group

doi:10.1007/s00415-019-09215-1

Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults

J Neurol. 2019 Apr;266(4):816. doi: 10.1007/s00415-019-09215-1.

Authors

Alvaro Cobo-Calvo^{1

2}, María Sepúlveda³, Hyacintha d'Indy⁴, Thais Armangué^{3

5}, Anne Ruiz⁴, Elisabeth Maillart⁶, Caroline Papeix⁶, Bertrand Audoin⁷, Helene Zephir⁸, Damien Biotti⁹, Jonathan Ciron⁹, Francoise Durand-Dubief¹⁰, Nicolas Collongues¹¹, Xavier Ayrignac¹², Pierre Labauge¹², Eric Thouvenot¹³, Alexis Montcuquet¹⁴, Romain Deschamps¹⁵, Nuria Solà-Valls³, Sara Llufriu³, Yolanda Blanco³, Jerome de Seze¹¹, Sandra Vukusic^{10

16

17}, Albert Saiz³, Romain Marignier^{10

4

17}; OFSEP Group; REEM Group

Affiliations

¹ Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation and Centre de référence pour les maladies inflammatoires rares du cerveau et de la moelle (MIRCEM), Hôpital Neurologique Pierre Wertheimer Hospices Civils de Lyon, 59 boulevard Pinel, BRON cedex, 69677, Lyon, France. alvaro.cobo-calvo@chu-lyon.fr.
² Lyon's Neuroscience Research Center, U1028 INSERM, UMR5292 CNRS, FLUID Team, 69008, Lyon, France. alvaro.cobo-calvo@chu-lyon.fr.
³ Institut d´Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Center of Neuroimmunology, Neurology Department, Hospital Clínic, Barcelona, Spain.
⁴ Lyon's Neuroscience Research Center, U1028 INSERM, UMR5292 CNRS, FLUID Team, 69008, Lyon, France.
⁵ Pediatric Neuroimmunology Unit, Department of Neurology, Sant Joan de Deu Children's Hospital, University of Barcelona, Barcelona, Spain.
⁶ Department of Neurology, Pitié-Salpêtrière Hospital, APHP, Paris, France.
⁷ Pôle de Neurosciences Cliniques, Service de Neurologie, Aix Marseille Univ, APHM, Hôpital de La Timone, Marseille, France.
⁸ Pôle des Neurosciences et de l'Appareil Locomoteur, CHU de Lille, Université de Lille, LIRIC, UMR 995, Lille, France.
⁹ Department of Neurology B4, Bâtiment Pierre-Paul Riquet, University Hospital of Purpan, Toulouse, France.
¹⁰ Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation and Centre de référence pour les maladies inflammatoires rares du cerveau et de la moelle (MIRCEM), Hôpital Neurologique Pierre Wertheimer Hospices Civils de Lyon, 59 boulevard Pinel, BRON cedex, 69677, Lyon, France.
¹¹ Department of Neurology and Clinical Investigation Center, Strasbourg University Hospital, Strasbourg, France.
¹² Multiple Sclerosis Unit, Montpellier University Hospital, Montpellier, France.
¹³ Department of Neurology, Hôpital Carémeau, Nimes University Hospital, Nimes, France.
¹⁴ Department of Neurology, Hôpital de Dupuytren, Limoges, France.
¹⁵ Department of Neurology, Fondation A. De Rothschild, Paris, France.
¹⁶ Lyon's Neuroscience Research Center, Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292, 69003, Lyon, France.
¹⁷ Université Claude Bernard Lyon 1, Université de Lyon, 69100, Lyon, France.

PMID: 30759286
DOI: 10.1007/s00415-019-09215-1

Abstract

The original version of this article unfortunately contained a mistake.

Publication types

Published Erratum